
Research articles


BMS Top 10 Medicines by Sales in Q2 '24

Top 10 BioPharma Companies by Revenue (2003 to 2023)

AbbVie Q2 Earnings: Immunology Strength Overshadows Aesthetics Challenges

The Shifting Spending Priorities of Big Pharma

The Prize of the Eyes: Eylea & Vabysmo in Opthalmology

J&J's Q2 Earnings and Key Milestones in Immunology and Oncology

Small Molecule GLP-1 Overview
